81 Biggest Movers From Yesterday
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday.
Vanda Pharmaceuticals Q3 EPS $0.14 Misses $0.16 Estimate, Sales $70.09M Miss $75.00M Estimate
Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.16 by 12.5 percent. This is a 27.27 percent increase over earnings of $0.11 per share
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Vanda Pharmaceuticals Earnings Preview
Vanda Pharmaceuticals (NASDAQ:VNDA) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement.
Analysts estimate that Vanda Pharmaceuticals will likely report an Earnings Per Share (EPS) of $0.16
Vanda Pharmaceuticals Granted Patent ‘Treatment of circadian rhythm disorders’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6678&f=G&l=50&d=PTXT&p=134&S1=20210817&OS=20210817&RS=20210817
Novavax Appoints New CFO Amid Inordinate Delay In COVID-19 Vaccine Authorization
Novavax, Inc. (NASDAQ: NVAX) announced new hires to its executive team even as it is stymied by the delay in getting authorization for its COVID-19 vaccine in the U.S.
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.
Vanda Pharmaceuticals Posts Clinical Trial Titled ‘Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers’ To ClinicalTrials.Gov
https://clinicaltrials.gov/ct2/show/NCT04969211
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell
• Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.